Fornix DBS for mild AD: methods and baseline population description published by Dove Medical Press

Share Article

The ADvance trial was designed to examine deep brain stimulation of the fornix as a treatment for mild AD.

The Open Access Journal of Clinical Trials has published the methodology “Deep brain stimulation targeting the fornix for mild Alzheimer dementia: design of the ADvance randomized controlled trial”.

As Prof. Dr Greg S. Martin, Editor-in-Chief, explains “Although only reporting the design of a study, the topic (Alzheimer's) is important throughout the developed world and the manuscript also provides some information about a novel therapy (deep-brain stimulation).”

The Open Access Journal of Clinical Trials is an international, peer- reviewed, open access, online journal. Publishing original research, reports, editorials, reviews and commentaries on all aspects of clinical trial design, management, legal, ethical and regulatory issues, case record form design, data collection, quality assurance and data auditing methodologies.

Dove Medical Press Ltd is a privately held company specializing in the publication of Open Access peer-reviewed journals across the broad spectrum of science, technology and especially medicine.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Angela Jones
Dove Medical Press
+649 443 3060 Ext: 207
Email >
Visit website